Myriad Genetics (MYGN) EV/EBITDA: History & Chart

Myriad Genetics, Inc.(MYGN)

Medical - Diagnostics & Research · Salt Lake City, UT

$4.35-0.23 (-5.02%)

Delayed quote: Oct 6, 2026, 12:30 PM EDT

About Myriad Genetics, Inc.

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; FirstGene; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; University of Texas M.D. Anderson Cancer Center; Mayo Foundation for Medical Education and Research; Children’s Medical Center in Boston; Institut Curie and INSERM; and Eurobio Scientific SA. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

Salt Lake City, UT

2,700 employees

www.myriad.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Samraat S. Raha

View full financials

MYGN EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

EV/EBITDA RATIO AVG TTM

30.26x

EV/EBITDA RATIO AVG 3Y

22.88x

EV/EBITDA RATIO AVG 5Y

18.64x

EV/EBITDA RATIO AVG 10Y

12.67x

EV/EBITDA RATIO AVG 15Y

N/A

EV/EBITDA RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Myriad Genetics, Inc. (MYGN)	$410.85M	N/A	30.26x	22.88x	18.64x
Neurogene Inc. (NGNE)vs ›	$410.80M	N/A	N/A	N/A	N/A
Shoulder Innovations, Inc. (SI)vs ›	$411.45M	N/A	N/A	N/A	N/A
Carlsmed, Inc. (CARL)vs ›	$404.78M	N/A	N/A	N/A	N/A
Atea Pharmaceuticals, Inc. (AVIR)vs ›	$414.54M	N/A	5.73x	28.73x	28.73x
Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›	$414.16M	N/A	N/A	N/A	N/A
Prothena Corporation plc (PRTA)vs ›	$419.05M	N/A	16.39x	16.39x	16.39x
Rezolute, Inc. (RZLT)vs ›	$421.28M	N/A	N/A	N/A	N/A
Senseonics Holdings, Inc. (SENS)vs ›	$421.41M	N/A	N/A	N/A	N/A
MapLight Therapeutics, Inc. (MPLT)vs ›	$396.99M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/EBITDA RATIO

TTM

Myriad Genetics, Inc. (MYGN)

$410.85M

N/A

30.26x

22.88x

18.64x

Neurogene Inc. (NGNE)vs ›

$410.80M

N/A

Shoulder Innovations, Inc. (SI)vs ›

$411.45M

N/A

Carlsmed, Inc. (CARL)vs ›

$404.78M

N/A

Atea Pharmaceuticals, Inc. (AVIR)vs ›

$414.54M

N/A

5.73x

28.73x

Eikon Therapeutics, Inc. Common Stock (EIKN)vs ›

$414.16M

N/A

Prothena Corporation plc (PRTA)vs ›

$419.05M

N/A

16.39x

Rezolute, Inc. (RZLT)vs ›

$421.28M

N/A

Senseonics Holdings, Inc. (SENS)vs ›

$421.41M

N/A

MapLight Therapeutics, Inc. (MPLT)vs ›

$396.99M

N/A

EV/EBITDA Ratio FAQ

What is the EV/EBITDA ratio for Myriad Genetics, Inc. (MYGN)?

The EV/EBITDA ratio for MYGN stock is N/A.

What is the estimated TTM average EV/EBITDA ratio for Myriad Genetics, Inc. (MYGN)?

The estimated TTM average EV/EBITDA ratio for MYGN stock is 30.26x.

What is the estimated 3Y average EV/EBITDA ratio for Myriad Genetics, Inc. (MYGN)?

The estimated 3Y average EV/EBITDA ratio for MYGN stock is 22.88x.

What is the estimated 5Y average EV/EBITDA ratio for Myriad Genetics, Inc. (MYGN)?

The estimated 5Y average EV/EBITDA ratio for MYGN stock is 18.64x.

What is the estimated 10Y average EV/EBITDA ratio for Myriad Genetics, Inc. (MYGN)?

The estimated 10Y average EV/EBITDA ratio for MYGN stock is 12.67x.

DATE	EV/EBITDA RATIO
2020-05-05	30.16x
2020-05-04	30.89x
2020-05-01	30.13x
2020-04-30	31.25x
2020-04-29	31.71x
2020-04-28	30.14x
2020-04-27	31.06x
2020-04-24	29.63x
2020-04-23	29.31x
2020-04-22	29.05x
2020-04-21	29.63x
2020-04-20	30.81x
2020-04-17	30.47x
2020-04-16	29.63x
2020-04-15	29.45x
2020-04-14	31.42x
2020-04-13	30.71x
2020-04-09	30.89x
2020-04-08	29.21x
2020-04-07	30.11x
2020-04-06	31.01x
2020-04-03	25.77x
2020-04-02	27.59x
2020-04-01	27.25x
2020-03-31	29.29x
2020-03-30	29.63x
2020-03-27	28.87x
2020-03-26	30.26x
2020-03-25	29.55x
2020-03-24	28.53x
2020-03-23	26.01x
2020-03-20	26.40x
2020-03-19	25.60x
2020-03-18	21.58x
2020-03-17	22.53x
2020-03-16	23.67x
2020-03-13	27.57x
2020-03-12	26.28x
2020-03-11	28.82x
2020-03-10	31.01x
2020-03-09	30.59x
2020-03-06	32.80x
2020-03-05	34.31x
2020-03-04	35.03x
2020-03-03	33.40x
2020-03-02	35.68x
2020-02-28	34.93x
2020-02-27	34.35x
2020-02-26	35.46x
2020-02-25	35.56x
2020-02-24	36.73x
2020-02-21	38.38x
2020-02-20	38.79x
2020-02-19	38.96x
2020-02-18	38.38x
2020-02-14	37.99x
2020-02-13	38.20x
2020-02-12	38.88x
2020-02-11	38.50x
2020-02-10	38.67x
2020-02-07	40.72x
2020-02-06	40.57x
2020-02-05	40.87x
2020-02-04	39.57x
2020-02-03	39.78x
2020-01-31	38.50x
2020-01-30	39.30x
2020-01-29	39.84x
2020-01-28	40.26x
2020-01-27	39.49x
2020-01-24	39.73x
2020-01-23	39.94x
2020-01-22	39.83x
2020-01-21	39.46x
2020-01-17	39.85x
2020-01-16	40.10x
2020-01-15	40.65x
2020-01-14	40.58x
2020-01-13	39.11x
2020-01-10	39.09x
2020-01-09	39.08x
2020-01-08	39.18x
2020-01-07	38.62x
2020-01-06	38.41x
2020-01-03	37.49x
2020-01-02	38.12x
2019-12-31	37.97x
2019-12-30	37.08x
2019-12-27	37.40x
2019-12-26	37.50x
2019-12-24	38.15x
2019-12-23	34.92x
2019-12-20	38.19x
2019-12-19	37.95x
2019-12-18	37.38x
2019-12-17	37.53x
2019-12-16	36.31x
2019-12-13	35.89x
2019-12-12	35.16x
2019-12-11	34.60x
2019-12-10	35.65x
2019-12-09	35.18x
2019-12-06	35.93x
2019-12-05	36.00x
2019-12-04	36.20x
2019-12-03	34.88x
2019-12-02	35.40x
2019-11-29	36.09x
2019-11-27	36.50x
2019-11-26	36.36x
2019-11-25	37.38x
2019-11-22	35.36x
2019-11-21	35.30x
2019-11-20	35.16x
2019-11-19	35.32x
2019-11-18	34.84x
2019-11-15	34.83x
2019-11-14	34.54x
2019-11-13	34.05x
2019-11-12	34.15x
2019-11-11	34.20x
2019-11-08	33.44x
2019-11-07	33.30x
2019-11-06	32.89x
2019-11-05	21.16x
2019-11-04	34.31x
2019-11-01	33.11x
2019-10-31	32.99x
2019-10-30	32.74x
2019-10-29	32.52x
2019-10-28	32.72x
2019-10-25	31.86x
2019-10-24	32.08x
2019-10-23	31.08x
2019-10-22	31.71x
2019-10-21	30.77x
2019-10-18	30.11x
2019-10-17	29.97x
2019-10-16	29.85x
2019-10-15	29.41x
2019-10-14	29.28x
2019-10-11	29.13x
2019-10-10	28.51x
2019-10-09	27.99x
2019-10-08	28.00x
2019-10-07	28.62x
2019-10-04	28.58x
2019-10-03	28.40x
2019-10-02	27.86x
2019-10-01	27.99x
2019-09-30	28.31x
2019-09-27	28.16x
2019-09-26	28.45x
2019-09-25	29.52x
2019-09-24	30.44x
2019-09-23	27.54x
2019-09-20	27.08x
2019-09-19	27.70x
2019-09-18	27.54x
2019-09-17	28.21x
2019-09-16	28.19x
2019-09-13	27.19x
2019-09-12	27.37x
2019-09-11	26.80x
2019-09-10	25.29x
2019-09-09	24.42x
2019-09-06	24.25x
2019-09-05	24.64x
2019-09-04	23.61x
2019-09-03	23.64x
2019-08-30	23.58x
2019-08-29	23.40x
2019-08-28	23.14x
2019-08-27	22.23x
2019-08-26	22.68x
2019-08-23	22.61x
2019-08-22	23.09x
2019-08-21	25.03x
2019-08-20	24.47x
2019-08-19	25.02x
2019-08-16	25.27x
2019-08-15	23.27x
2019-08-14	25.41x
2019-08-13	37.96x
2019-08-12	38.55x
2019-08-09	38.71x
2019-08-08	39.02x
2019-08-07	38.25x
2019-08-06	38.19x
2019-08-05	38.52x
2019-08-02	40.01x
2019-08-01	38.33x
2019-07-31	25.50x
2019-07-30	25.80x
2019-07-29	25.15x
2019-07-26	25.33x
2019-07-25	24.70x
2019-07-24	25.17x
2019-07-23	24.87x
2019-07-22	24.35x
2019-07-19	24.99x
2019-07-18	23.51x
2019-07-17	23.20x
2019-07-16	22.95x
2019-07-15	23.01x
2019-07-12	22.73x
2019-07-11	22.29x
2019-07-10	23.39x
2019-07-09	23.52x
2019-07-08	23.94x
2019-07-05	24.29x
2019-07-03	24.55x
2019-07-02	24.54x
2019-07-01	24.16x
2019-06-28	24.40x
2019-06-27	23.57x
2019-06-26	23.38x
2019-06-25	20.26x
2019-06-24	20.56x
2019-06-21	20.95x
2019-06-20	21.29x
2019-06-19	21.55x
2019-06-18	21.49x
2019-06-17	21.95x
2019-06-14	21.35x
2019-06-13	22.95x
2019-06-12	21.70x
2019-06-11	21.02x
2019-06-10	21.45x
2019-06-07	22.16x
2019-06-06	22.05x
2019-06-05	22.37x
2019-06-04	22.07x
2019-06-03	21.44x
2019-05-31	21.96x
2019-05-30	21.61x
2019-05-29	20.98x
2019-05-28	20.90x
2019-05-24	21.74x
2019-05-23	21.45x
2019-05-22	22.00x
2019-05-21	22.76x
2019-05-20	22.31x
2019-05-17	22.96x
2019-05-16	23.29x
2019-05-15	23.40x
2019-05-14	23.43x
2019-05-13	23.64x
2019-05-10	24.61x
2019-05-09	24.32x
2019-05-08	23.77x
2019-05-07	29.51x
2019-05-06	30.04x
2019-05-03	29.51x
2019-05-02	28.58x
2019-05-01	27.57x
2019-04-30	27.22x
2019-04-29	27.50x
2019-04-26	27.43x
2019-04-25	27.30x

DATE

EV/EBITDA RATIO

2020-05-05

30.16x

2020-05-04

30.89x

2020-05-01

30.13x

2020-04-30

31.25x

2020-04-29

31.71x

2020-04-28

30.14x

2020-04-27

31.06x

2020-04-24

29.63x

2020-04-23

29.31x

2020-04-22

29.05x

2020-04-21

29.63x

2020-04-20

30.81x

2020-04-17

30.47x

2020-04-16

29.63x

2020-04-15

29.45x

2020-04-14

31.42x

2020-04-13

30.71x

2020-04-09

30.89x

2020-04-08

29.21x

2020-04-07

30.11x

2020-04-06

31.01x

2020-04-03

25.77x

2020-04-02

27.59x

2020-04-01

27.25x

2020-03-31

29.29x

2020-03-30

29.63x

2020-03-27

28.87x

2020-03-26

30.26x

2020-03-25

29.55x

2020-03-24

28.53x

2020-03-23

26.01x

2020-03-20

26.40x

2020-03-19

25.60x

2020-03-18

21.58x

2020-03-17

22.53x

2020-03-16

23.67x

2020-03-13

27.57x

2020-03-12

26.28x

2020-03-11

28.82x

2020-03-10

31.01x

2020-03-09

30.59x

2020-03-06

32.80x

2020-03-05

34.31x

2020-03-04

35.03x

2020-03-03

33.40x

2020-03-02

35.68x

2020-02-28

34.93x

2020-02-27

34.35x

2020-02-26

35.46x

2020-02-25

35.56x

2020-02-24

36.73x

2020-02-21

38.38x

2020-02-20

38.79x

2020-02-19

38.96x

2020-02-18

38.38x

2020-02-14

37.99x

2020-02-13

38.20x

2020-02-12

38.88x

2020-02-11

38.50x

2020-02-10

38.67x

2020-02-07

40.72x

2020-02-06

40.57x

2020-02-05

40.87x

2020-02-04

39.57x

2020-02-03

39.78x

2020-01-31

38.50x

2020-01-30

39.30x

2020-01-29

39.84x

2020-01-28

40.26x

2020-01-27

39.49x

2020-01-24

39.73x

2020-01-23

39.94x

2020-01-22

39.83x

2020-01-21

39.46x

2020-01-17

39.85x

2020-01-16

40.10x

2020-01-15

40.65x

2020-01-14

40.58x

2020-01-13

39.11x

2020-01-10

39.09x

2020-01-09

39.08x

2020-01-08

39.18x

2020-01-07

38.62x

2020-01-06

38.41x

2020-01-03

37.49x

2020-01-02

38.12x

2019-12-31

37.97x

2019-12-30

37.08x

2019-12-27

37.40x

2019-12-26

37.50x

2019-12-24

38.15x

2019-12-23

34.92x

2019-12-20

38.19x

2019-12-19

37.95x

2019-12-18

37.38x

2019-12-17

37.53x

2019-12-16

36.31x

2019-12-13

35.89x

2019-12-12

35.16x

2019-12-11

34.60x

2019-12-10

35.65x

2019-12-09

35.18x

2019-12-06

35.93x

2019-12-05

36.00x

2019-12-04

36.20x

2019-12-03

34.88x

2019-12-02

35.40x

2019-11-29

36.09x

2019-11-27

36.50x

2019-11-26

36.36x

2019-11-25

37.38x

2019-11-22

35.36x

2019-11-21

35.30x

2019-11-20

35.16x

2019-11-19

35.32x

2019-11-18

34.84x

2019-11-15

34.83x

2019-11-14

34.54x

2019-11-13

34.05x

2019-11-12

34.15x

2019-11-11

34.20x

2019-11-08

33.44x

2019-11-07

33.30x

2019-11-06

32.89x

2019-11-05

21.16x

2019-11-04

34.31x

2019-11-01

33.11x

2019-10-31

32.99x

2019-10-30

32.74x

2019-10-29

32.52x

2019-10-28

32.72x

2019-10-25

31.86x

2019-10-24

32.08x

2019-10-23

31.08x

2019-10-22

31.71x

2019-10-21

30.77x

2019-10-18

30.11x

2019-10-17

29.97x

2019-10-16

29.85x

2019-10-15

29.41x

2019-10-14

29.28x

2019-10-11

29.13x

2019-10-10

28.51x

2019-10-09

27.99x

2019-10-08

28.00x

2019-10-07

28.62x

2019-10-04

28.58x

2019-10-03

28.40x

2019-10-02

27.86x

2019-10-01

27.99x

2019-09-30

28.31x

2019-09-27

28.16x

2019-09-26

28.45x

2019-09-25

29.52x

2019-09-24

30.44x

2019-09-23

27.54x

2019-09-20

27.08x

2019-09-19

27.70x

2019-09-18

27.54x

2019-09-17

28.21x

2019-09-16

28.19x

2019-09-13

27.19x

2019-09-12

27.37x

2019-09-11

26.80x

2019-09-10

25.29x

2019-09-09

24.42x

2019-09-06

24.25x

2019-09-05

24.64x

2019-09-04

23.61x

2019-09-03

23.64x

2019-08-30

23.58x

2019-08-29

23.40x

2019-08-28

23.14x

2019-08-27

22.23x

2019-08-26

22.68x

2019-08-23

22.61x

2019-08-22

23.09x

2019-08-21

25.03x

2019-08-20

24.47x

2019-08-19

25.02x

2019-08-16

25.27x

2019-08-15

23.27x

2019-08-14

25.41x

2019-08-13

37.96x

2019-08-12

38.55x

2019-08-09

38.71x

2019-08-08

39.02x

2019-08-07

38.25x

2019-08-06

38.19x

2019-08-05

38.52x

2019-08-02

40.01x

2019-08-01

38.33x

2019-07-31

25.50x

2019-07-30

25.80x

2019-07-29

25.15x

2019-07-26

25.33x

2019-07-25

24.70x

2019-07-24

25.17x

2019-07-23

24.87x

2019-07-22

24.35x

2019-07-19

24.99x

2019-07-18

23.51x

2019-07-17

23.20x

2019-07-16

22.95x

2019-07-15

23.01x

2019-07-12

22.73x

2019-07-11

22.29x

2019-07-10

23.39x

2019-07-09

23.52x

2019-07-08

23.94x

2019-07-05

24.29x

2019-07-03

24.55x

2019-07-02

24.54x

2019-07-01

24.16x

2019-06-28

24.40x

2019-06-27

23.57x

2019-06-26

23.38x

2019-06-25

20.26x

2019-06-24

20.56x

2019-06-21

20.95x

2019-06-20

21.29x

2019-06-19

21.55x

2019-06-18

21.49x

2019-06-17

21.95x

2019-06-14

21.35x

2019-06-13

22.95x

2019-06-12

21.70x

2019-06-11

21.02x

2019-06-10

21.45x

2019-06-07

22.16x

2019-06-06

22.05x

2019-06-05

22.37x

2019-06-04

22.07x

2019-06-03

21.44x

2019-05-31

21.96x

2019-05-30

21.61x

2019-05-29

20.98x

2019-05-28

20.90x

2019-05-24

21.74x

2019-05-23

21.45x

2019-05-22

22.00x

2019-05-21

22.76x

2019-05-20

22.31x

2019-05-17

22.96x

2019-05-16

23.29x

2019-05-15

23.40x

2019-05-14

23.43x

2019-05-13

23.64x

2019-05-10

24.61x

2019-05-09

24.32x

2019-05-08

23.77x

2019-05-07

29.51x

2019-05-06

30.04x

2019-05-03

29.51x

2019-05-02

28.58x

2019-05-01

27.57x

2019-04-30

27.22x

2019-04-29

27.50x

2019-04-26

27.43x

2019-04-25

27.30x

EV/EBITDA Ratio: N/A

MYGN EV/EBITDA Ratio Chart

MYGN Average EV/EBITDA Ratio Chart

MYGN EV/EBITDA Ratio Metrics

MYGN Competitors' EV/EBITDA Ratio

EV/EBITDA Ratio Formula & Definition

EV/EBITDA Ratio FAQ

MYGN EV/EBITDA Ratio History

Related Metrics